Knowledge Center
Article / 2013
Scale-up of spray dried amorphous solid dispersions
Source:
European Industrial Pharmacy, December 2013
With an increasing number of relatively insoluble drugs in development today, there is a need to develop and use platform technologies capable of addressing solubility issues. Among the different alternatives, the use of stabilised amorphous solid dispersions is becoming increasingly popular, with pharmaceutical spray drying being one of the key technologies used in their preparation. In spray dried dispersions (SDD), the active pharmaceutical ingredient (API) is molecularly dispersed in a polymeric matrix. The polymer is used to stabilise the amorphous, metastable form of the drug and sustain supersaturation of the API in solution/biological fluids, thereby increasing bioavailability.
Related links
Also in the Knowledge Center
Poster / May 03, 2022
Use of PAT tools in the development, monitor and control of continuous manufacturing processes
Read more
Scientific Article
Poster / May 03, 2022
Enhancing the “right first time” concept in Continuous Manufacturing – Development strategy
Read more
Scientific Article
Scientific Article